Próximo seminario “Antiproliferative activities of myxomycete polysaccharides” Viernes 24 de abril de 2026 | 13:30h Ponente: Hanh Tran Grupo de Investigación: BIONUC Título: “Antiproliferative activities of myxomycete polysaccharides” Lugar: Aula E del área docente del HUCA

Don't miss next IUOPA's seminar: 

“Antiproliferative activities of myxomycete polysaccharides” with Hanh Tran

🗓️ Friday, April 24th · 13.30h
📍 Aula E del área docente del HUCA

II Minicongreso de Estudiantes del Programa de Doctorado en Biomedicina y Oncología Molecular del IUOPA Lidia Sainz Ledo (Grupo de Investigación de Epigenética del Cáncer) y Jaime San Juan Guardado (Grupo de Investigación de Tumores Raros), son los ganadores del II Minicongreso de Estudiantes del Progra...

🎉Congratulations to our lab’s Jaime San Juan Guardado (@jaimesanjuan.bsky.social) and Lidia Sainz Ledo for winning the II Student Minicongress of the PhD Program in Biomedicine and Molecular Oncology (@iuopa.bsky.social) www.unioviedo.es/IUOPA/ii-min...

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Luis Paz-Ares, the Head of Medical Oncology Service at Hospital Universitario 12 de Octubre who will close the Symposium with the lecture "SCLC: from biology to therapy - some advances"

📅 Thursday 14th | 13.00 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Sara Alonso Hematologist at  Hospital Universitario Central de Asturias (HUCA) who will close "SESSION IV. Targeted therapies: novel opportunities and challenges" 

📅 Thursday 14th | 10.10 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce  F. Xavier Avilés Jurado from the Head and Neck tumors Unit at @hospitalclinic.bsky.social  who will participate in "SESSION V. Advances in diagnosis"

📅 Thursday 14th | 12.30 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Víctor Moreno, Director of the Oncology Data Analytics Program at Institut Català d'Oncologia (ICO), who will open "SESSION V. Advances in diagnosis"

📅 Thursday 14th | 11.30 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Paolo Bossi Associate Professor Medical Oncology at  Humanitas University who will participate in "SESSION IV. Targeted therapies: novel opportunities and challenges"

📅 Thursday 14th | 9.35 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Laura Muinelo from Instituto de Investigación Sanitaria de Santiago de Compostela who will participate in "SESSION V. Advances in diagnosis"

📅 Thursday 14th | 12.00 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Julio Delgado, Haematologist at @hospitalclinic.bsky.social    who will open "SESSION IV. Targeted therapies: novel opportunities and challenges" with the lecture "The development of academic CAR T cells"

📅 Thursday 14th | 9.00 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce Javier A. Menéndez Group Leader at Institut Català d'Oncologia (ICO) who will close "SESSION III. Cancer metabolism: mechanisms and therapeutic opportunities"

📅 Wednesday 13th | 18.40 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce
@alteamanzanolab.bsky.social  Junior Group Leader at
@cabimer.bsky.social  who will participate in "SESSION III. Cancer metabolism: mechanisms and therapeutic opportunities".

📅 Wednesday 13th | 18.05 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce  Alejo Efeyan  Group Leader at @cniostopcancer.bsky.social   who will open "SESSION III. Cancer metabolism: mechanisms and therapeutic opportunities.

📅 Wednesday 13th | 17.30 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce María Muñoz Caffarel Group Leader at 
@biogipuzkoa.bsky.social  who will participate in "SESSION II. Molecular and translational advances in cancer invasion and metastatic dissemination".

📅 Wednesday 13th | 16.10 h

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce  Roger Gomis Research Professor at @irbbarcelona.org who will open "SESSION II. Molecular and translational advances in cancer invasion and metastatic dissemination".

📅 Wednesday 13th | 15.00 h

🩸 Conocemos como leucemia al conjunto de cánceres de la sangre que se se inicia en la médula ósea.

📖 𝗜𝗨𝗢𝗣𝗔 𝗱𝗲 𝗹𝗮 𝗔 𝗹𝗮 𝗭:
en esta sección repasamos conceptos importantes en la investigación del cáncer. Cada semana, una nueva letra, un nuevo concepto

IV IUOPA International Symposium About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Check the full program and enroll:

Meet the speakers at our International Symposium 

Today we introduce @ferrannadeu.bsky.social  Posdoctoral Researcher at
@idibaps.bsky.social   who will participate in "SESSION I. Cancer genomics and epigenomics: mechanisms and clinical implications"

📅 Wednesday 13th | 11.35h

Broad-host-range Kayvirus phages preferentially infect Staphylocococcus aureus cells with β-glycosylated WTA, the most common bacterial form in the human host Jurado A, Gómez-Cambronero CC, Rodríguez A, Lopez D, García P, Fernández L. Int J Antimicrob Agents. 2026 Feb 27:107755. doi: 10.1016/j.ijantimicag.2026.107755. Online ahead of print. PMID: 41765188 Free article. The work of the Dairy Safe Group (IPLA-CSIC) and the Epigenetic Cancer Research Team (IUOPA) has been highlighted, with the participation of Carlos Colmenero

🔊 Latest publication by IUOPA's Cancer Epigenetics team: